LIVN

LivaNova PLC

Price

$76.08

return (12m)

44.17%

p/e

22.26

p/bv

3.17

DIVIDEND YIELD

0.00%

LIVN price

LivaNova

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LIVN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.04%

3 months

-5.98%

1 year

44.17%

2 years

41.37%

5 years

-9.31%

10 years

34.37%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LIVN

Valuation

P/E

22.26

Sector 1.07

Industry 11.69

P/BV

3.17

Sector 1.86

Industry 1.81

P/Revenue (PSR)

2.85

Sector 1.54

Industry 0.83

EV/EBITDA

90.55

Sector -45.27

Industry -32.36

EV/EBIT

154.78

Sector -48.49

Industry 13.03

P/EBITDA

20.14

Sector -31.51

Industry -2.64

P/EBIT

29.01

Sector -42.93

Industry -1.03

P/Total Assets

1.59

Sector 0.85

Industry 0.65

P/Net Current Assets

-14.45

Sector -25.71

Industry -42.17

P/Working Capital

13.20

Sector -4.14

Industry -39.61

EPS

3.43

Sector -0.70

Industry 0.78

BVPS

24.11

Sector 4.52

Industry 10.94

Efficiency

Gross Margin

68.10%

Sector 49.51%

Industry 48.27%

EBITDA Margin

11.23%

Sector -280.81%

Industry -20.27%

EBIT Margin

12.74%

Sector -19.82%

Industry -1.44%

Net Profit Margins

12.81%

Sector -24.01%

Industry -7.17%

Asset Turnover

0.15

Sector 0.13

Industry 0.21

Profitability

ROE

14.23%

Sector -23.78%

Industry -9.44%

ROA

7.14%

Sector -24.20%

Industry -7.93%

ROIC

9.49%

Sector -584.46%

Industry -90.63%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.06%

Payout

0.00%

Sector -

Industry 5.40%

Debt

Current Ratio

1.45

Sector 1.91

Industry 1.23

Net Debt / EBITDA

-5.17

Sector -23.21

Industry -28.79

Net Debt / EBIT

-8.84

Sector -17.93

Industry 0.28

Net Debt / Equity

-0.17

Sector -0.68

Industry -0.01

Gross Debt / Equity

0.22

Sector -0.72

Industry -0.36

Equity/Assets

0.50

Sector 0.46

Industry 0.34

Liabilities/Assets

0.50

Sector 0.50

Industry 0.60

Growth

5Y Revenue CAGR

7.28%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals LIVN

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF LivaNova ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$76.08

Fair Value

$43.14

Upside

-43.30%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LIVN LivaNova PLC	$76.08	46.93%	0.00%	22.26	3.17	14.23%	12.81%
ABT Abbott Laboratories	$102.98	-18.11%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$94.21	2.59%	3.28%	21.29	2.19	10.29%	13.93%
BSX Boston Scientific Corp.	$43.00	-55.32%	0.00%	17.05	2.51	14.73%	17.49%
TMDX TransMedics Group Inc.	$75.52	-32.40%	0.00%	18.01	5.27	29.28%	22.69%
RMD ResMed Inc.	$235.32	-12.90%	1.07%	21.81	5.05	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$529.01	-16.47%	0.00%	35.95	25.41	70.67%	25.03%
COHR Coherent Inc.	$263.23	128.64%	0.00%	74.48	5.34	7.16%	11.31%
SYK Stryker Corp.	$281.63	-21.79%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.99	-5.55%	4.20%	17.81	1.74	9.80%	6.30%
INMD InMode Ltd.	$14.28	-6.67%	0.00%	10.78	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$188.98	3.76%	2.30%	53.38	2.06	3.85%	6.29%
DXCM DexCom Inc.	$83.47	28.02%	0.00%	32.03	12.21	38.14%	20.12%
EW Edwards Lifesciences Corp.	$86.45	18.51%	0.00%	47.85	4.48	9.37%	15.43%
ALGN Align Technology Inc.	$144.44	11.29%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$27.88	-18.03%	2.88%	20.20	4.39	21.74%	9.20%
IRMD iRadimed Corporation	$89.83	25.48%	1.46%	48.20	10.92	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$91.77	-2.21%	1.08%	21.13	1.35	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LIVN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT LivaNova

LivaNova PLC

Average Investor10 user rating

4.0 (1 people)

United States

11 years

Founded: 2015

1993

Time since IPO - 33 years

4.000

Employees

LivaNova PLC (United States) is listed on the Nasdaq and has a market capitalization of $4.20 billion, with shareholders equity totaling $1.33 billion.

The company employs approximately 4.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, LivaNova PLC reported $1.47 billion in revenue, generating net income of $188.55 million.

Key financial metrics include a P/E ratio of 22.26, a price-to-book (P/B) ratio of 3.17, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LIVN.

Market cap

$4.20 billion

Net worth

$1.33 billion

$1,325,322,000.00

Assets

$2.64 billion

$2,640,861,000.00

Total Shares Outstanding

54.97 million

54,971,000

Average Daily Trading Volume

$666.42 Thousand

$666,419.32

Sector

Health

Industry

Medical Supplies and Equipment

LIVN

LIVN revenue and profits

Financial Results LIVN

DRAG THE FRAME TO SEE MORE DATA

LIVN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$90.44 16,55% (12M)

P/E

22.64

3.07%

ROE

6.12%

P/BV

1.39

CI - Cigna

$289.52 0,50% (12M)

P/E

10.91

2.19%

ROE

16.04%

P/BV

1.75

CNC - Centene

$70.17 96,06% (12M)

P/E

-6.39

0.00%

ROE

-22.53%

P/BV

1.44

HUM - Humana

$427.77 65,91% (12M)

P/E

40.85

0.81%

ROE

6.63%

P/BV

2.71

SNY - Sanofi

$39.77 --15,57% (12M)

P/E

3.76

4.41%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$253.92 35,83% (12M)

P/E

29.77

2.03%

ROE

24.76%

P/BV

7.37

LLY - Eli Lilly

$1,210.72 47,40% (12M)

P/E

39.18

0.57%

ROE

78.84%

P/BV

30.89

HCA - HCA Healthcare

$470.59 12,51% (12M)

P/E

14.42

0.68%

ROE

-213.15%

P/BV

-30.74